Treatment of agitation in dementia

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 8, 1999, Pages 11-20

  Tariot, Pierre N ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Monroe Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LORAZEPAM; PAROXETINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SELEGILINE; SERTRALINE; THIORIDAZINE; TRAZODONE; VALPROATE SEMISODIUM;

AGITATION; ANXIETY NEUROSIS; COGNITIVE DEFECT; DEMENTIA; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; HUMAN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

CAREGIVERS; CONFUSION; DECISION TREES; DEMENTIA; ELECTROCONVULSIVE THERAPY; ESTROGENS; HUMANS; LITHIUM; PHOTOTHERAPY; PROPRANOLOL; PSYCHOMOTOR AGITATION; PSYCHOTROPIC DRUGS; REFERRAL AND CONSULTATION;

EID: 0032909442     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Tariot PN, Blazina L. In: Morris J, ed. Handbook of Dementing Illnesses. New York, NY: Marcel Dekker; 1993:461-475
2. Tariot PN, Mack JL, Patterson MB, et al. The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer's disease. Am J Psychiatry 1995;152:1349-1357
3. Merriam AE, Aronson MK, Gaston K, et al. The psychiatric symptoms of Alzheimer's disease. J Am Geriatr Soc 1988;36:7-12
4. Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly, I: a conceptual review. J Am Geriatr Soc 1986;34:711-721
5. Kalunian DA, Binder RL, McNiel DE. Violence by geriatric patients who need psychiatric hospitalization. J Clin Psychiatry 1990;51:340-343
6. Nilsson K, Palmstierna T, Wistedt B. Aggressive behavior in hospitalized psychogeriatric patients. Acta Psychiatr Scand 1988;78:172-178
7. Tariot PN, Schneider LS, Katz IR. Anticonvulsant and other non-neuroleptic treatment of agitation in dementia. J Geriatr Psychiatry Neurol 1995;8 (suppl 1):500-512
8. Tariot PN. General approaches to behavioral disturbances. In: Reichman ME, Katz P, eds. Psychiatric Care in the Nursing Home. New York, NY: Oxford University Press; 1996:10-22
9. Tariot PN. Treatment strategies for agitation and psychosis in dementia. J Clin Psychiatry 1996;57(suppl 14):21-29
10. Tariot PN, Erb R, Podgorski CA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998; 155:54-61
11. Leibovici A, Tariot PN. Agitation associated with dementia: a systematic approach to treatment. Psychopharmacol Bull 1988;24:39-42
12. Maxfield MC, Lewis RE, Cannon S. Training staff to prevent aggressive behavior of cognitively impaired elderly during bathing and grooming. J Gerontol Nurs 1996;22:37-43
13. Roberts B, Algase D. Victims of Alzheimer's disease and the environment. Nurs Clin North Am 1988;23:83-93
14. Food and Drug Administration. Omnibus Budget Reconciliation Act guidelines of 1987. 54 Federal Register: Rockville, Md; 1989:5316-5336
15. Board of Directors of the American Association for Geriatric Psychiatry. Clinical Practice Committee of the American Geriatrics Society, and Committee on Long-Term Care and Treatment for the Elderly, American Psychiatric Association. Psychotherapeutic medications in the nursing home. J Am Geriatr Soc 1992;40:946-949
16. American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997;154(suppl):1-39
17. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989;146:577-587
18. Schneider LS, Pollock VE, Lyness SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990;38:553-563
19. Pollock BG, Mulsant BH. Antipsychotics in older patients: a safety perspective. Drugs Aging 1995;6:312-323
20. Goldberg RJ, Goldberg J. Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience. Int Psychogeriatr 1997;9:65-68
21. Brecher M. Risperidone in the treatment of psychosis and aggressive behavior in patients with dementia. Presented at the 8th Congress of the International Psychogeriatric Association; August 17-22, 1997; Jerusalem, Israel
22. De Deyn P. Risperidone in the treatment of behavioral disturbances in dementia. Presented at the 8th Congress of the International Psychogeriatric Association; August 17-22, 1997; Jerusalem, Israel
23. McManus DQ, Arvanitis LA, Kowalcyk BB, and the Seroquel Trial 48 Study Group. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry. In press
24. Arvanitis LA, Rak IW. Efficacy, safety and tolerability of Seroquel (quetiapine) in elderly subjects with psychotic disorders [abstract]. Schizophr Res 1997;24:196
25. Arvanitis LA, Miller BG, and the Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-246
26. Cantillon M, Brunswick R, Molina D, et al. Buspirone vs haloperidol: a double-blind trial for agitation in a nursing home population with Alzheimer's disease. Am J Geriatr Psychiatry 1996;4:263-267
27. Sultzer DL, Gray KF, Gunay I, et al. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 1997;5:60-69
28. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicenter study. Br J Psychiatry 1990;157:894-901
29. Porsteinsson A, Tariot PN. Nursing homes and long-term care. In: Clark C, Trojanowski J, eds. Neurodegenerative Dementia: Clinical Features and Pathological Mechanism. New York, NY: McGraw Hill. In press
30. Tariot PN, Erb R, Leibovici A, et al. Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994;42:1160-1166
31. Chambers CA, Bain J, Rosbottom R, et al. Carbamazepine in senile dementia and overactivity: a placebo-controlled double-blind trial. IRCS Med Sci 1982;10:505-506
32. Tariot PN, Frederiksen KM, Erb R, et al. Lack of carbamazepine toxicity in frail nursing home patients: a controlled study. J Am Geriatr Soc 1995;43: 1026-1029
33. Porsteinsson A, Tariot PN, Erb R, et al. An open trial of valproate for agitation in dementia. Am J Geriatr Psychiatry 1997;5:344-351
34. Goad DL, Davis CM, Liem P, et al. The use of selegiline in Alzheimer's patients with behavior problems. J Clin Psychiatry 1991;52:342-345
35. Sano M, Ernesto C, Thomas RG, et al. The Alzheimer's Disease Cooperative Study. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-1222
36. Carlyle W, Killick L, Ancill R. ECT: an effective treatment in the screaming demented patient. J Am Geriatr Soc 1991;39:637-639
37. Holmberg S, Tariot PN, Challipalli R. Efficacy of ECT for agitation in dementia: a case report. Am J Geriatr Psychiatry 1996;4:330-334
38. Satlin A, Volicer L, Ross V, et al. Bright-light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am J Psychiatry 1992;149:1028-1032
39. Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol 1996;9:1-6
40. Beck C, Heacock P. Nursing interventions for patients with Alzheimer's disease. Nurs Clin North Am 1988;23:95-124
41. Smith M, Buckwalter K, Mitchell S. Geriatric Mental Health Training Series. New York, NY: Springer Publishing Company; 1993
42. Gwyther L, Rabins P. Practical approaches for treating behavioral symptoms of people with mild to moderate Alzheimer's disease. Primary Psychiatry 1996:27-37